Frontal predominant encephalopathy with early paligraphia as a distinctive signature of CAR T-cell therapy-related neurotoxicity

Chimeric antigen receptor (CAR) T-cell therapy is an emerging highly effective treatment for refractory haematological malignancies. Unfortunately, its therapeutic benefit may be hampered by treatment-related toxicities, including neurotoxicity. Early aggressive treatment is paramount to prevent neu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pensato, Umberto, Amore, Giulia, D’Angelo, Roberto, Rinaldi, Rita, Nicodemo, Marianna, Rondelli, Francesca, Mondini, Susanna, Santoro, Rossella, Sammali, Susanna, Farolfi, Andrea, Spinardi, Luca, Faccioli, Luca, Casadei, Beatrice, Dicataldo, Michele, Bonifazi, Francesca, Zinzani, Pierluigi, Cortelli, Pietro, Stracciari, Andrea, Guarino, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Short Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381707/
https://www.ncbi.nlm.nih.gov/pubmed/34424399
http://dx.doi.org/10.1007/s00415-021-10766-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381707/
https://www.ncbi.nlm.nih.gov/pubmed/34424399
http://dx.doi.org/10.1007/s00415-021-10766-5

Ejemplares similares